Abstract
Implantable cardiac defibrillators (ICDs) are the mainstay for the prevention of sudden cardiac death (SCD) in high-risk patients. Dialysis patients have been excluded from major clinical trials, and thus data in this population are scant. No study has reported on outcomes of ICD therapy during hemodialysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have